Evaluation of the Effect of Local Injection of Ozone and Corticosteroid and Prolotropics Under Sonography on Treatment of Tennis Elbow Syndrome (Elbow Tennis)

Evaluation of the Effect of Local Injection of Ozone and Corticosteroid and Prolotropics Under Sonography on Elbow Syndrome Tennis Players (TB): A Multi-centered Double-Blind Randomized Clinical Trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20151017024572N16

Enrollment

Registered

2018-06-24

Start date

2017-08-23

Completion date

Unknown

Last updated

2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tennis player elbow syndrome. Mononeuropathy in diseases classified elsewhere

Interventions

Intervention 1: Intervention group (ozone therapy): 2cc ozone 20µg / L, at the joint of the common extensor tendon under ultrasound guidance. Intervention 2: Intervention group (porlotherapy): 2cc dex

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Anxiety in the outer part of the ear for a month Localized tenderness in the external region of the armpit (at the point of attachment of the extensors of the forearm) Exacerbation of pain during supination on the back of the head while maintaining flexion. Exacerbation of pain during dorsiflexion of the wrist against resistance Exacerbation of pain as well as punching along with the pressure of the hand

Exclusion criteria

Exclusion criteria: There are symptoms for more than 4 weeks or history of trauma to the elbow - History of connective tissue disease or diffuse pain syndrome (such as fibromyalgia, chronic pain syndrome - Inflammatory arthropathy - Use of previous therapies for external epicondylitis - The possibility of creating heavy work Full Radiolysis Brevis Extension Cardiac Tendon Radiculopathy Full Radiolysis Brevis Extension Cardiac Tendon Aphrodisiac Taking anticoagulants Existing Injection Detection

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: Before injection, 2 weeks and 8 weeks after injection. Method of measurement: Visual Analog Scale (VAS).	—

Secondary

Measure	Time frame
Clinical Global Impression. Timepoint: Before injection, 1 weeks and 8 weeks after injection. Method of measurement: Clinical Global Impression Questionnaire.;Patient Global Impression of Improvement. Timepoint: Before injection, 1 weeks and 8 weeks after injection. Method of measurement: Patient Global Impression of Improvement Questionnaire.;Tennis Elbow Evaluation. Timepoint: Before injection, 1 weeks and 8 weeks after injection. Method of measurement: Patient-rated Tennis Elbow Evaluation (PRTEE) Questionnaire.;Extensor tendon thickness. Timepoint: Before injection, 1 weeks and 8 weeks after injection. Method of measurement: Sonography.	—

Measure

Time frame

Clinical Global Impression. Timepoint: Before injection, 1 weeks and 8 weeks after injection. Method of measurement: Clinical Global Impression Questionnaire.;Patient Global Impression of Improvement. Timepoint: Before injection, 1 weeks and 8 weeks after injection. Method of measurement: Patient Global Impression of Improvement Questionnaire.;Tennis Elbow Evaluation. Timepoint: Before injection, 1 weeks and 8 weeks after injection. Method of measurement: Patient-rated Tennis Elbow Evaluation (PRTEE) Questionnaire.;Extensor tendon thickness. Timepoint: Before injection, 1 weeks and 8 weeks after injection. Method of measurement: Sonography.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Arash Babaei

Iran University of Medical Sciences

babaei-ghazani.a@iums.ac.ir+98 21 8214 1229

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026